{"disease":{"id":"posterior-reversible-encephalopathy-syndrome","name":"posterior reversible encephalopathy syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05433870","title":"Inflammatory Biomarkers for the Diagnosis of oPRES","phase":"","overall_status":"COMPLETED","enrollment_count":621,"lead_sponsor_name":"Dunjin Chen","has_results":false},{"nct_id":"NCT05310513","title":"The Predictors of ICU Admission of oPRES","phase":"","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"Dunjin Chen","has_results":false},{"nct_id":"NCT05143710","title":"The Clinical and Prognostic Features of PRES","phase":"","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"Dunjin Chen","has_results":false},{"nct_id":"NCT03470467","title":"Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Ictal Group","has_results":false},{"nct_id":"NCT04950270","title":"Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University Hospital, Tours","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}